Actively Recruiting

Age: 18Years +
All Genders
NCT06336239

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

Led by Beijing Anzhen Hospital · Updated on 2024-09-19

3000

Participants Needed

27

Research Sites

53 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The association between Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) is well established. Traditional risk factors for CVD and CKD are similar, with type 2 diabetes mellitus (T2DM) being the most prevalent risk factor. However, CKD is underdiagnosed and undertreated in patients with CVD. Further understanding of the combination of CKD in CVD patients is important to formulate prevention and treatment strategies for CVD patients and high-risk groups, reduce adverse events in CVD patients, and prevent progression of CKD to End Stage Renal Disease (ESRD).

CONDITIONS

Official Title

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with type 2 diabetes combined with one or more cardiovascular diseases (hypertension, coronary heart disease, atrial fibrillation, heart failure)
  • Visiting or receiving treatment in the cardiology outpatient or inpatient department during the study period
  • Able to provide informed consent (electronic or paper)
Not Eligible

You will not qualify if you...

  • Pregnant or lactating women
  • Patients undergoing dialysis
  • Diseases causing elevated albuminuria such as severe infection or confirmed primary glomerular disease
  • Currently receiving treatment for malignant tumors (surgery, chemotherapy, radiotherapy, or targeted therapy)
  • Cachexia with a CSS score of 5 or higher
  • Severe liver disease (Child-Pugh grade C)
  • Participation in an interventional clinical trial within the past three months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 27 locations

1

Beijing Sixth Hospital

Beijing, Beijing Municipality, China

Actively Recruiting

2

Fangshan District First Hospital

Beijing, Beijing Municipality, China

Completed

3

Peking University Third Hospital

Beijing, Beijing Municipality, China

Completed

4

Chinese PLA Army Characteristic Medical Center

Chongqing, Chongqing Municipality, China

Completed

5

Haidong City Second People's Hospital

Haidong, Gansu, China

Not Yet Recruiting

6

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

Not Yet Recruiting

7

First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Actively Recruiting

8

Ruyang County People's Hospita

Luoyang, Henan, China, 471201

Actively Recruiting

9

Luoyang Sixth People's Hospita

Luoyang, Henan, China

Completed

10

Yongcheng People's Hospital

Yongcheng, Henan, China

Completed

11

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Not Yet Recruiting

12

Zhangjiagang Sixth People's Hospital

Zhangjiagang, Jiangsu, China

Completed

13

Shenyang Ninth People's Hospital

Shenyang, Liaoning, China

Actively Recruiting

14

Shenyang Tenth People's Hospital

Shenyang, Liaoning, China

Active, Not Recruiting

15

Jining First People's Hospital

Jining, Shandong, China

Not Yet Recruiting

16

Tai'an First People's Hospital

Tai’an, Shandong, China

Completed

17

Weihai Central Hospital

Weihai, Shandong, China

Not Yet Recruiting

18

Jing'an District Central Hospital of Shanghai

Shanghai, Shanghai Municipality, China

Completed

19

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Not Yet Recruiting

20

Zhongshan Hospital Fudan University Qingpu Branch

Shanghai, Shanghai Municipality, China

Actively Recruiting

21

Qinyuan County People's Hospital

Changzhi, Shanxi, China

Completed

22

Shanxi Bethune Hospital

Taiyuan, Shanxi, China

Actively Recruiting

23

The First Affiliated Hospital of Xi'an Jiaotong University

XI Ail, Shanxi, China

Not Yet Recruiting

24

The Fifth People's Hospital of Sichuan Province

Chengdu, Sichuan, China

Not Yet Recruiting

25

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Actively Recruiting

26

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

Not Yet Recruiting

27

Taizhou Central Hospital

Taizhou, Zhejiang, China

Actively Recruiting

Loading map...

Research Team

X

Xin Du, Doctor

CONTACT

Y

Yu Kong, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study | DecenTrialz